INTRODUCTION {#sec1-1}
============

5,10-methylenetetrahydrofolate reductase (MTHFR) has key roles in purine and thymidylate biosynthesis through one-carbon metabolism (OCM) in DNA and amino acid methylations, RNA synthesis, and in neurotransmitter formation.\[[@ref1]\] MTHFR helps channel OCM units between the DNA cycle and the methylation cycle through the OCM.\[[@ref2][@ref3][@ref4]\] Decrease in *MTHFR* activity, which is involved in the homocysteine metabolism, affects homocysteine level, an indication of the role of *MTHFR* in folate metabolism. Mutations in *MTHFR* are known to cause hyperhomocysteinemia and homocystinuria causing various metabolic problems. The most common polymorphisms occurring in the *MTHFR* gene are C677T and A1298C. Since *MTHFR* affects methylation through S-adenosylmethionine, folate distribution, and homocysteine metabolism, genetic defects in *MTHFR* have a potentially negative and positive regulatory effect on disease risk.\[[@ref5][@ref6][@ref7]\]

Psychiatric symptoms are reported to be related to Vitamin B12, folate, and homocysteine levels.\[[@ref8][@ref9][@ref10][@ref11][@ref12]\] This fact shows the importance of Vitamin B12, folate, and homocysteine in carbon transfer (methylation), which is essential for the production of serotonin, catecholamines, and other monoamine neurotransmitters.\[[@ref13]\] The link between folate deficiency and depressive disorders has been the topic of previous.\[[@ref14][@ref15]\] Later, the focus moved on to the increased folate prevalence and Vitamin B12 deficiency in depressed patients.\[[@ref16][@ref17]\] Observations on the antidepressant effects of folate may support the importance of folate in psychopathology.\[[@ref18][@ref19]\] A few studies showed the effects of excessive OCM in anxiety disorders especially.\[[@ref20][@ref21][@ref22][@ref23]\] To the best of our knowledge, there are no studies on the relationship between *MTHFR* polymorphisms and obsessive-compulsive disorder (OCD). For this reason, we planned this study to investigate if the *MTHFR* polymorphisms in OCD patients are of etiopathogenetic significance and to show the effect of these polymorphisms at early- and late-onset of OCD.

MATERIALS AND METHODS {#sec1-2}
=====================

Patients {#sec2-1}
--------

The study sample size was detected by power analysis using G-Power. Patients with a total of 64 OCD diagnoses according to the diagnostic and statistical manual of mental disorders V (DSM-V) diagnostic criteria according to clinical interview scales were divided into two groups according to the age of onset, early and late onset. Beginning age was taken as 15, and those who started after 15 years old were evaluated as late-onset OCD. As a healthy control, 64 patients with no OCD diagnosed and without psychotropic drugs or other medications were included in the study. Familial stories were assessed and those with psychiatric illnesses were recorded. Both healthy controls and OCD patients with schizophrenia, bipolar disorder, or high genetic transmission were not included in the study.

Ethics {#sec2-2}
------

This study was conducted in compliance with the good clinical practice and applicable regulatory procedure required by the Declaration of Helsinki. The study was approved by the Institutional Review Board (IRB) in May 2018. The IRB-approved informed consent forms were obtained from each participant before any study-related procedure.

Sociodemographic form and psychometrics tests {#sec2-3}
---------------------------------------------

Sociodemographic findings of both groups were obtained by applying a sociodemographic data form. The Yale--Brown Obsessive-Compulsion Scale (Y-BOCS), Hamilton Depression Rating Scale (HAM-D), the Hamilton Anxiety Rating Scale (HAM-A), and the DSM-III-R personality disorders Structured Clinical Interview for DSM-II (SCID-II) were used to measure severity of illness in the OCD group. SCIs were administered for the DSM-IV Axis I Disorders (SCID-I).

DNA isolation {#sec2-4}
-------------

Genomic DNA was isolated from peripheral blood samples according to the manufacturer\'s instructions (Qiagen, Germany). DNA concentration was evaluated by absorbance methodology at 260 nm and DNA purity at 260/280 nm using a NanoDrop 1000 Spectrophotometer V3.7 (Thermo Scientific, USA).

Genotyping {#sec2-5}
----------

SNPs were determined by real-time PCR using a panel of Light SNP assay from Way2 gene (assays based on Light Cycler HybProbe^®^). The Light Cycler HybProbe^®^ in the LightSNP assay detects single-base mismatches, thus enabling the analysis of polymorphisms. The amplification process was followed by a melting curve analysis on Light Cycler 2.0 (Roche, Germany). Functional variants mapping in *MTHFR* gene C677T and A1298C polymorphisms were evaluated.

Data analysis {#sec2-6}
-------------

Amplification values of *MTHFR* C677T and A1298C genotypes were obtained at 640 nm. Mutant presence was detected at 54.5°C Tm for *MTHFR* C677T and the wild-type at 63.0°C. For A1298C, the mutant was detected at 58.5°C Tm and the wild-type at 49°C.

Statistical analysis {#sec2-7}
--------------------

Data were analyzed by one-way analysis of variance and Chi-squared tests using SPSS-Windows 15 software package (IBM, Armonk, NY, USA).

RESULTS {#sec1-3}
=======

Comparison of sociodemographical and clinical characteristics of the OCD and control groups is summarized in [Table 1](#T1){ref-type="table"}. Statistical differences in age and education level were present between the groups (*P* = 0.004 and *P* = 0.001, respectively). A statistically significant difference was also present in marital status between the groups (*P* = 0.001). There was no significant difference in gender distribution between the groups (*P* \> 0.05). The difference in the tic story between the groups was also statistically significant (*P* = 0.002). There were no statistically significant differences in obsession type, compulsion type, triggered life story, starting story, HAM-D, HAM-A, Y-BOCS total, Y-BOCS Obsess (Y-BOCS obsessions), and Y-BOCS Comp (Y-BOCS compulsion) between the early- and late-onset OCD patients (*P* \> 0.05) \[[Table 1](#T1){ref-type="table"}\].

###### 

Demographical and clinical comparisons of groups

                             EO-OCD group, *n* (%)   LO-OCD group, *n* (%)   Control group, *n* (%)   *χ*^2^   df      *P*                     
  -------------------------- ----------------------- ----------------------- ------------------------ -------- ------- --------- -------- ---- ----------
  Gender                                                                                                                                       
   Female                    25 (76.9)               27 (84.6)               38 (64.3)                3.04     2       0.217                   
   Male                      7 (23.1)                5 (15.4)                26 (35.7)                                                         
  Marital status                                                                                                                               
   Married                   15 (23.1)               26 (73.1)               28 (75.0)                20.34    6       0.001\*                 
   Single                    26 (69.2)               14 (23.1)               15 (21.4)                                                         
   Divorced                  1 (3.8)                 0 (0.0)                 1 (3.6)                                                           
   Widow                     1 (3.8)                 1 (3.8)                 0                                                                 
  Ticstory                                                                                                                                     
   Yes                       14 (36.4)               6 (0.0)                 0 (0.0)                  9.38     1       0.002\*                 
   No                        18 (63.6)               26 (100)                64 (100)                                                          
  Triggered life event                                                                                                                         
   Yes                       16 (50)                 24 (75)                 \-                       4.69     1       0.07                    
   No                        16 (50)                 8 (25)                                                                                    
  Starting story                                                                                                                               
   Sudden                    6 (8.0)                 9 (21.7)                \-                       1.81     1       0.237                   
   Slow                      26 (92.0)               23 (78.3)                                                                                 
  Obsessions                                                                                                                                   
   Aggression                4 (8.2)                 3 (6.1)                                          0.123    1       1.00                    
   Contamination             16 (32.7)               20 (40.8)                                        2.34     1       0.19                    
   Symmetry                  10 (20.4)               10 (20.4)                                        0.014    1       1.00                    
   Miscellaneous             8 (16.3)                2 (4.1)                                          4.22     1       0.04                    
   Sexual                    1 (2.0)                 0                                                0.98     1       1.00                    
   Religious                 5 (10.2)                4 (8.2)                                          0.091    1       1.00                    
   Somatic                   2 (4.1)                 1 (2.0)                                          0.313    1       0.51                    
   Cleaning                  16 (32.7)               12 (24.5)                                        0.980    1       0.24                    
  Compulsions                                                                                                                                  
   Cleaning                  16 (32.7)               19 (38.8)                                        1.380    1       0.34                    
   Ritualistic               1 (2.0)                 2 (4.1)                                          0.40     1       0.60                    
   Counting                  8 (16.3)                0                                                9.17     1       0.004                   
   Ordering/arranging        10 (20.4)               10 (20.4)                                        0.014    1       1.00                    
   Miscellaneous             8 (16.3)                2 (4.1)                                          4.22     1       0.07                    
   Hoarding                  6 (12.2)                2 (4.1)                                          2.20     1       0.24                    
                             M                       SD                      M                        SD       M       SD        *F*      df   *P*
  Age                        27.80                   11.25                   36.64                    10.70    35.96   8.18      6.076    2    0.004\*
  Educational level (year)   11.12                   3.4                     9.52                     4.84     9.6     13.76     7.733    2    0.001\*
  HAM-D                      17.09                   5.51                    14.65                    7.88     2.63    3.22      29.266   2    \<0.0001
  HAM-A                      20.55                   11.68                   18.04                    9.10     2.14    2.47      35.626   2    \<0.0001
  Y-BOCS total               24                      6.25                    22                       6.78     0.0     \-        6.420    2    0.956
  Y-BOCS obsess              13.3                    3.05                    10.8                     3.41     0.0     \-        9.615    2    0.937
  Y-BOCS comp                11.7                    3.49                    11.1                     3.45     0.0     \-        5.455    2    0.996

\*Significant *P*\<0.05. M -- Mean average; SD -- Standard deviation; Y-BOCS -- Yale-Brown Obsessive-Compulsion Scale; Y-BOCS obsess -- Y-BOCS obsessions; Y-BOCS comp -- Y-BOCS compulsion; HAM-A -- Hamilton Anxiety Rating Scale; HAM-D -- Hamilton Depression Rating Scale; OCD -- Obsessive-compulsive disorder; EO-OCD -- Early-onset OCD; LO-OCD -- Early-onset OCD

Based on the genotype analysis, the genotype distribution of *MTHFR* C677T gene polymorphism was 39% CC, 42% CT, and 19% TT in the OCD group, whereas it was 39% CC, 36% CT, and 25% TT in the control group. For *MTHFR* A1298C polymorphism, the genotype distribution was 30% AA, 54% AC, and 16% CC in the OCD group and 30% AA, 55% AC, and 15% CC in the control group. Underlying allele frequencies were calculated as 61% C, 39% T for C677T and 62% C, 38% T for A1298C variant in the early-onset OCD group. In the late-onset OCD group, the allele frequencies were 59% C, 41% T for C677T and 55% A, 45% A for A1298C variant. In the control group, the allele frequencies were 57% C, 43%T for C677T and 52% A, 48% A for A1298C variant. No significant difference was found with Chi-squared test between the early- and late-onset OCD group and the control group in terms of the genotype and allele distributions (*P* \> 0.05) \[[Table 2](#T2){ref-type="table"}\]. There was also no significant difference between gender, marital status, tic story, obsessions, compulsions, Y-BOCS Total, Y-BOCS Obsess, Y-BOCS Comp, genotype, and allele distributions in the late- and early-onset OCD patients (*P* \> 0.05) \[[Table 3](#T3){ref-type="table"}\].

###### 

The genotype distributions and allele frequencies for methylenetetrahydrofolate reductase gene polymorphisms in groups

  Groups    *MTHFR C677T*   *P*   *MTHFRA1298C*   *P*                                                
  --------- --------------- ----- --------------- ------ ------ ------- ---- ---- ---- ------ ------ -------
  EO-OCD    13              13    6               0.61   0.39   0.596   14   13   6    0.62   0.38   0.781
  LO-OCD    12              14    6               0.59   0.41           10   14   7    0.55   0.45   
  Control   25              23    16              0.57   0.43           19   29   16   0.52   0.48   

*MTHFR* -- 5,10-methylenetetrahydrofolate reductase; OCD -- Obsessive-compulsive disorder; EO-OCD -- Early-onset OCD; LO-OCD -- Early-onset OCD

###### 

Comparison of 5,10-methylenetetrahydrofolate reductase gene polymorphisms with demographical and clinical features of groups

  Groups                *MTHFR C677T*   *P*   *MTHFR A1298C*   *P*                    
  --------------------- --------------- ----- ---------------- ------- ---- ---- ---- -------
  Gender                                                                              
   Female               39              34    13               0.384   36   40   15   0.380
   Male                 18              16    8                12      16   9         
  Marital status                                                                      
   Married              29              27    13               0.384   22   32   16   0.937
   Single               19              17    19               19      22   13        
   Divorced             1               1     0                1       1    0         
   Widow                1               1     0                0       2    0         
  Tic story                                                                           
   EO-OCD               26              15    8                0.197   15   21   4    0.942
   LO-OCD               6               6     3                9       11   4         
  Obsessions                                                                          
   Aggression                                                                         
    EO-OCD              25              22    9                0.754   20   22   14   0.350
    LO-OCD              10              9     5                8       11   5         
   Contamination                                                                      
    EO-OCD              13              8     6                0.210   8    12   6    0.164
    LO-OCD              23              23    8                20      21   13        
   Symmetry                                                                           
    EO-OCD              20              16    7                0.210   15   19   9    0.583
    LO-OCD              15              15    17               13      14   10        
   Miscellaneous                                                                      
    EO-OCD              25              23    8                0.208   19   24   13   0.198
    LO-OCD              10              8     6                9       9    6         
   Sexual                                                                             
    EO-OCD              29              25    8                0.406   22   26   14   0.812
    LO-OCD              6               6     6                8       8    5         
   Religious                                                                          
    EO-OCD              26              22    8                0.223   20   23   13   0.197
    LO-OCD              11              11    8                8       10   6         
   Somatic                                                                            
    EO-OCD              29              25    8                0.406   21   28   13   0.418
    LO-OCD              5               5     6                7       5    6         
  Compulsions                                                                         
   Cleaning                                                                           
    EO-OCD              12              10    7                0.290   19   20   13   0.164
    LO-OCD              22              22    7                9       14   6         
   Ritualistic                                                                        
    EO-OCD              30              25    9                0.000   21   29   14   0.000
    LO-OCD              5               7     5                7       5    5         
   Counting                                                                           
    EO-OCD              26              23    9                0.789   20   24   13   0.496
    LO-OCD              9               9     5                8       10   5         
   Ordering/arranging                                                                 
    EO-OCD              22              18    7                0.508   15   22   10   0.410
    LO-OCD              13              14    7                13      12   9         
   Hoarding                                                                           
    EO-OCD              25              24    8                0.192   19   25   13   0.188
    LO-OCD              10              8     6                9       9    6         
   Miscellaneous                                                                      
    EO-OCD              28              23    7                0.160   20   25   13   0.946
    LO-OCD              7               12    7                8       9    7         
   Y-BOCS total                                                                       
    EO-OCD              24              29    42               1.000   11   23   20   1.000
    LO-OCD              26              20    5                10      22   19        
   Y-BOCS obsess                                                                      
    EO-OCD              26              30    42               1.000   11   23   20   1.000
    LO-OCD              26              20    8                        11   24   23   
   Y-BOCS comp                                                                        
    EO-OCD              24              30    42               1.000   11   23   20   1.000
    LO-OCD              26              20    8                        11   24   23   

OCD -- Obsessive-compulsive disorder; EO-OCD -- Early-onset OCD; LO-OCD -- Early-onset OCD; Y-BOCS -- Yale--Brown Obsessive-Compulsion Scale; Y-BOCS obsess -- Y-BOCS obsessions; Y-BOCS comp -- Y-BOCS compulsion; *MTHFR* -- 5,10-methylenetetrahydrofolate reductase

DISCUSSION {#sec1-4}
==========

Psychiatric symptoms have been reported to be linked to Vitamin B12, folate, and homocysteine levels. Several studies have shown the effects of excessive carbon metabolism in anxiety disorders, especially OCD. Folate deficiency, high homocysteine levels, impaired methylation, and monoamine metabolism were reported in OCD patients by Atmaca *et al*.\[[@ref21]\] Another study also reported high homocysteine levels and Vitamin B12 deficiency in some OCD patients.\[[@ref24]\] One limitation of the current study is that serum levels of Vitamin B12, folate, and homocysteine were not measured in participants.

There are studies in the literature that question the association of OCD with folate, homocysteine, and Vitamin B12, but none with *MTHFR* gene polymorphisms. Considering the main role of MTHFR in brain function and neurodevelopment,\[[@ref25][@ref26]\] common genetic variances are reported in psychiatric disorders through family and twin studies.\[[@ref27][@ref28][@ref29][@ref30]\] Therefore, this report investigated the potential link between OCD and the MTHFR gene polymorphisms.

Genetic modifications affecting the MTFHR level or function decreases 5-methyltetrahydrofolate level further resulting in increased homocysteine. Major depression was reported to be correlated with both improper folate metabolism and high homocysteine level, which may be due to the MTHFR polymorphisms.\[[@ref31][@ref32][@ref33]\] Moreover, MTHFR C677T and A1298C polymorphisms were linked to major depression and related treatment options.\[[@ref33][@ref34][@ref35]\] Since there are studies showing the relationship between MTHFR gene polymorphisms and major depression in the literature, severe depressive OCD patients having high HAM-D scores were excluded in this study. The average HAM-D score of the OCD participants in our study was 16 with only five participants having a HAM-D score higher than 27. According to these scores, the majority of our patients had mild depressive symptoms and five had moderate depressive symptoms. None of the participants were categorized to have major depressive disorder according to DSM-V diagnostic criteria. The fact that our participants had only mild and moderate depressive symptoms was another limitation of this study.

The link between *MTFHR* gene polymorphisms and the major psychiatric disorders, including bipolar disorder and schizophrenia, has been exhaustively studied. However, they were mostly inconclusive or reported mixed findings.\[[@ref36][@ref37][@ref38][@ref39][@ref40][@ref41][@ref42]\] For example, in a study investigating the *MTHFR* C677T polymorphism on schizophrenia and affective disorder, it was concluded that the homozygote T allele does not play an important role in the pathogenesis of the diseases.\[[@ref36]\]

There are many meta-analyses in the literature that reveal the relationship between psychiatric diseases and *MTHFR* gene polymorphisms. Two meta-analyses by Lewis *et al*.,\[[@ref43]\] on 2427 participants and Muntjewerff *et al*.\[[@ref44]\] on 4986 participants reported an elevated risk for schizophrenia with the TT genotype of *MTHFR* C677T polymorphism. The link between the *MTHFR* C677T polymorphism and several psychiatric disorders was also elucidated by two meta-analysis reports by Gilbody *et al*.\[[@ref39]\] and Zintzaras.\[[@ref45]\] The former report analyzed a total of 26 studies on schizophrenia (12 studies with over 6100 participants), bipolar disorder (4 studies with over 1600 participants), and unipolar depressive disorder (10 studies with over 11000 participants).\[[@ref39]\] The latter report, on the other hand, covered two more articles on the top of what is covered by the former meta-analysis report.\[[@ref40]\] Another meta-analysis report examined the links between the *MTHFR* C677T and A1298C polymorphisms with schizophrenia on over 9500 and 6100 participants, respectively.\[[@ref46]\] Furthermore, the links between the *MTHFR* C677T and A1298C polymorphisms with bipolar disorder were examined on over 2200 and 700 participants, respectively. While the *MTHFR* C677T polymorphism was examined in all of these meta-analyses, the A1298C was only examined in some of them. One striking result pointed out by Peerbooms *et al*. in their meta-analysis with over 9600 patients and 19800 control participants was that although the TT genotype was represented in small percentage of the patients, it was significantly related with schizophrenia, bipolar disorder, and unipolar depressive disorder.\[[@ref47]\] They also reported that the CC genotype of *MTHFR* A1298C polymorphism was also rare but significantly related with bipolar disorder not schizophrenia in their meta-analysis with over 3500 patients and 4400 control participants. In the current study, two polymorphisms of *MTHFR* showed approximately the same genotype profile in comparison of patient and control groups and early-/late-onset OCD groups. In comparison of the patient and control groups, the percentage of CT genotype in *MTHFR* C677T polymorphism was higher in OCD patients, but no statistical significance was detected in all comparisons.

Demographic differences in the participants may influence how *MTHFR* gene polymorphisms affect psychiatric disorders. Two studies revealed that demographic background and gender of participants might have close impact on the way *MTHFR* gene polymorphisms affect psychiatric disorders.\[[@ref45][@ref48]\] In this study, there was no statistically significant difference between the demographic features and *MTHFR* gene polymorphisms of OCD cases.

CONCLUSION {#sec1-5}
==========

This study was the first to investigate the relationship between early- and late-onset OCD and MTHFR gene polymorphisms, thus reflecting a section of the Turkish population. Our results lacked to show evidence that *MTHFR* gene polymorphisms play a role in the pathogenesis of OCD in Turkish participants. To clarify the effect of *MTHFR* C677T and A1298C polymorphisms in the OCD pathophysiology, the number of participants might be increased and biochemical data on folate metabolism might be investigated in the future studies.
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